Yıl: 2020 Cilt: 7 Sayı: 1 Sayfa Aralığı: 9 - 15 Metin Dili: İngilizce DOI: 10.5152/eurjrheum.2019.19072 İndeks Tarihi: 13-05-2021

Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis

Öz:
Objective: To evaluate whether there is any difference between radiographic axial spondyloarthritis (r-axSpA), also termed ankylosing spondylitis (AS), and non-radiographic (nr-) axSpA, with respect to subclinial myocardial dysfunction using speckle tracking echocardiography (STE).Methods: This was a cross-sectional case control study. We included 72 patients with AS, 38 patients with nr-axSpA, and 56 age-matched healthy subjects. Patients with cardiac disease and cardiac risk factors affecting STE were excluded. The disease burden evaluated by the BASDAI, BASFI, BAS-G, and ASAS-HI scores were comparable in both the r- and nr-axSpA groups. A detailed echocardiographic examination including the M-mode, Doppler, and STE was applied to whole study population.Results: Duration of the disease, the use of an anti-TNFα agent, and CRP levels were higher in patients with AS. Although the AS, nr-axSpA, and control groups had similar ejection fraction values (59±5.2, 60±4.6, 60±4.6, respectively, and p=0.499), the global longitudinal peak systolic strain (GLS) (20.5±3.3, 21.1±3.5, and 22.3±2.4, respectively, and p<0.05) was different between the groups. In a post-hoc analysis, GLS was not different between the nr-axSpA and control groups, and it was significantly lower in patients with AS. In the univariate analysis, peripheral arthritis (p=0.035) and age (p=0.032) were correlated with GLS. A multivariate regression analysis demonstrated that peripheral arthritis (p=0.009) was the only independent GLS predictor.Conclusion: Subclinical myocardial dysfunction as assessed by GLS was present in AS, but not in nr-ax-SpA patients. Thus, GLS could be used as a differentiating factor between radiographic and nr-axSpA patients.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Poddubnyy D, Sieper J. Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment. Curr Opin Rheumatol 2014; 26: 377-83. [CrossRef]
  • 2. Lauper K, Courvoisier DS, Chevallier P, Finckh A, Gabay C. Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. Arthritis Care Res 2018; 70: 1756-63. [CrossRef]
  • 3. Prati C, Puyraveau M, Guillot X, Verhoeven F, Wendling D. Deaths Associated with Ankylosing Spondylitis in France from 1969 to 2009. J Rheumatol 2017; 44: 594-8. [CrossRef]
  • 4. Kang KY, Her YH, Ju JH, Hong YS, Park SH. Radiographic progression is associated with increased cardiovascular risk in patients with axial spondyloarthritis. Modern Rheumatol 2016; 26: 601-6. [CrossRef]
  • 5. Okan T, Sari I, Akar S, Cece H, Goldeli O, Guneri S, et al. Ventricular diastolic function of ankylosing spondylitis patients by using conventional pulsed wave Doppler, myocardial performance index and tissue Doppler imaging. Echocardiography 2008; 25: 47-56.
  • 6. Gorcsan, J. and Tanaka H. Echocardiographic assessment of myocardial strain. J Am College Cardiol 2011; 58: 1401-1413. [CrossRef]
  • 7. Chen Y, Chung HY, Zhao CT, Wong A, Zhen Z, Tsang HHL, et al. Left ventricular myocardial dysfunction and premature atherosclerosis in patients with axial spondyloarthritis. Rheumatology 2014; 54: 292-301. [CrossRef]
  • 8. Ustun N, Kurt M, Nacar AB, Karateke HP, Guler H, Turhanoglu AD. Left ventricular systolic dysfunction in patients with ankylosing spondylitis without clinically overt cardiovascular disease by speckle tracking echocardiography. Rheumatol Int 2015; 35: 607-11. [CrossRef]
  • 9. Rudwaleit, M., van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68: 777-83. [CrossRef]
  • 10. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286-91.
  • 11. Akad K, Solmaz D, Sari I, Onen F, Akkoc N, Akar S. Performance of response scales of activity and functional measures of ankylosing spondylitis: numerical rating scale versus visual analog scale. Rheumatol Int 2013; 33: 2617-23. [CrossRef]
  • 12. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281-5.
  • 13. Doward L, Spoorenberg A, Cook S, Whalley D, Helliwell P, Kay L, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003; 62: 20-6. [CrossRef]
  • 14. Kiltz U, Van Der Heijde D, Boonen A, Cieza A, Stucki G, Khan M, et al. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis 2014; 74: 830-5. [CrossRef]
  • 15. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 1996; 35: 66-71. [CrossRef]
  • 16. Van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68: 1811-8. [CrossRef]
  • 17. Creemers M, Franssen M, Van’t Hof M, Gribnau F, Van de Putte L, Van Riel P. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005; 64: 127-9. [CrossRef]
  • 18. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16: 233-71. [CrossRef]
  • 19. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur J Echocardiogr 2016; 17: 1321-60. [CrossRef]
  • 20. Baraliakos X, Braun J. Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences? RMD open 2015; 1(Suppl. 1): e000053. [CrossRef]
  • 21. Brewerton D, Goddard D, Moore R, Revell P, Gibson D, Jones T, et al. The myocardium in ankylosing spondylitis: A clinical, echocardiographic, and histopathological study. Lancet 1987; 329: 995-8. [CrossRef]
  • 22. Ercan S, Goktepe F, Kisacik B, Pehlivan Y, Onat AM, Yavuz F, et al. Subclinical cardiovascular target organ damage manifestations of ankylosing spondylitis in young adult patients. Modern Rheumatol 2013; 23: 1063-8. [CrossRef]
  • 23. Caliskan M, Erdogan D, Gullu H, Yilmaz S, Gursoy Y, Yildirir A, et al. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis 2008; 196: 306-12. [CrossRef]
  • 24. Heslinga SC, Van Dongen CJ, Konings TC, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, et al. Diastolic left ventricular dysfunction in ankylosing spondylitis-a systematic review and meta-analysis. Semin Arthritis Rheum 2014; 44: 14-9. [CrossRef]
  • 25. Ryall NH, Helliwell P. A critical review of ankylosing spondylitis. Critical Reviews™ in Physical and Rehabilitation Medicine 1998; 10. [CrossRef]
  • 26. Spoorenberg A, Dougados M, Mielants H. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheum 1999; 26: 980-4.
  • 27. Peters MJ, Van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004; 34: 585-92. [CrossRef]
APA emren v, Gerçik Ö, Özdemir E, Solmaz D, KAHYA EREN N, Şimşek E, Tokaç M, Yapan Emren Z, Kabadayı G, Akar S (2020). Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. , 9 - 15. 10.5152/eurjrheum.2019.19072
Chicago emren volkan,Gerçik Önay,Özdemir Emre,Solmaz Dilek,KAHYA EREN NİHAN,Şimşek Ersin Çağrı,Tokaç Mehmet,Yapan Emren Zeynep,Kabadayı Gökhan,Akar Servet Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. (2020): 9 - 15. 10.5152/eurjrheum.2019.19072
MLA emren volkan,Gerçik Önay,Özdemir Emre,Solmaz Dilek,KAHYA EREN NİHAN,Şimşek Ersin Çağrı,Tokaç Mehmet,Yapan Emren Zeynep,Kabadayı Gökhan,Akar Servet Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. , 2020, ss.9 - 15. 10.5152/eurjrheum.2019.19072
AMA emren v,Gerçik Ö,Özdemir E,Solmaz D,KAHYA EREN N,Şimşek E,Tokaç M,Yapan Emren Z,Kabadayı G,Akar S Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. . 2020; 9 - 15. 10.5152/eurjrheum.2019.19072
Vancouver emren v,Gerçik Ö,Özdemir E,Solmaz D,KAHYA EREN N,Şimşek E,Tokaç M,Yapan Emren Z,Kabadayı G,Akar S Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. . 2020; 9 - 15. 10.5152/eurjrheum.2019.19072
IEEE emren v,Gerçik Ö,Özdemir E,Solmaz D,KAHYA EREN N,Şimşek E,Tokaç M,Yapan Emren Z,Kabadayı G,Akar S "Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis." , ss.9 - 15, 2020. 10.5152/eurjrheum.2019.19072
ISNAD emren, volkan vd. "Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis". (2020), 9-15. https://doi.org/10.5152/eurjrheum.2019.19072
APA emren v, Gerçik Ö, Özdemir E, Solmaz D, KAHYA EREN N, Şimşek E, Tokaç M, Yapan Emren Z, Kabadayı G, Akar S (2020). Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. European Journal of Rheumatology, 7(1), 9 - 15. 10.5152/eurjrheum.2019.19072
Chicago emren volkan,Gerçik Önay,Özdemir Emre,Solmaz Dilek,KAHYA EREN NİHAN,Şimşek Ersin Çağrı,Tokaç Mehmet,Yapan Emren Zeynep,Kabadayı Gökhan,Akar Servet Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. European Journal of Rheumatology 7, no.1 (2020): 9 - 15. 10.5152/eurjrheum.2019.19072
MLA emren volkan,Gerçik Önay,Özdemir Emre,Solmaz Dilek,KAHYA EREN NİHAN,Şimşek Ersin Çağrı,Tokaç Mehmet,Yapan Emren Zeynep,Kabadayı Gökhan,Akar Servet Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. European Journal of Rheumatology, vol.7, no.1, 2020, ss.9 - 15. 10.5152/eurjrheum.2019.19072
AMA emren v,Gerçik Ö,Özdemir E,Solmaz D,KAHYA EREN N,Şimşek E,Tokaç M,Yapan Emren Z,Kabadayı G,Akar S Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. European Journal of Rheumatology. 2020; 7(1): 9 - 15. 10.5152/eurjrheum.2019.19072
Vancouver emren v,Gerçik Ö,Özdemir E,Solmaz D,KAHYA EREN N,Şimşek E,Tokaç M,Yapan Emren Z,Kabadayı G,Akar S Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. European Journal of Rheumatology. 2020; 7(1): 9 - 15. 10.5152/eurjrheum.2019.19072
IEEE emren v,Gerçik Ö,Özdemir E,Solmaz D,KAHYA EREN N,Şimşek E,Tokaç M,Yapan Emren Z,Kabadayı G,Akar S "Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis." European Journal of Rheumatology, 7, ss.9 - 15, 2020. 10.5152/eurjrheum.2019.19072
ISNAD emren, volkan vd. "Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis". European Journal of Rheumatology 7/1 (2020), 9-15. https://doi.org/10.5152/eurjrheum.2019.19072